We are live on ! Find out more
AA

Ancora Advisors Portfolio holdings

AUM $4.7B
1-Year Est. Return 19.05%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+19.05%
3 Year Est. Return
+64.25%
5 Year Est. Return
+78.87%
10 Year Est. Return
+385.89%
AUM
$3.53B
AUM Growth
+$54.4M
Cap. Flow
+$63.6M
Cap. Flow %
1.8%
Top 10 Hldgs %
28.93%
Holding
2,322
New
188
Increased
441
Reduced
443
Closed
332

Sector Composition

Rank Sector Weight
1 Industrials 21.14%
2 Technology 11.35%
3 Consumer Discretionary 8.23%
4 Financials 7.93%
5 Healthcare 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIOAW
1826
DELISTED
Tio Tech A Warrants
TIOAW
$28 ﹤0.01%
6,700
RAMMW
1827
DELISTED
Aries I Acquisition Corporation
RAMMW
$26 ﹤0.01%
1,500
PORT.WS
1828
DELISTED
Southport Acquisition Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50
PORT.WS
$22 ﹤0.01%
467
-200
-30% -$8
RJAC.WS
1829
DELISTED
Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
RJAC.WS
$22 ﹤0.01%
2,500
PICC.WS
1830
DELISTED
Pivotal Investment Corporation III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
PICC.WS
$17 ﹤0.01%
2,529
PERF.WS
1831
DELISTED
Perfect Corp Warrants
PERF.WS
$16 ﹤0.01%
103
FNCL icon
1832
Fidelity MSCI Financials Index ETF
FNCL
$2.35B
0
ACB
1833
Aurora Cannabis
ACB
$165M
$14 ﹤0.01%
2
SIVB
1834
DELISTED
SVB Financial Group
SIVB
$14 ﹤0.01%
16
+6
+60% +$1.69K
SLACW
1835
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$11 ﹤0.01%
100
NTII
1836
DELISTED
NEUROBIOLOGICAL TECHNOLOGS INC
NTII
$3 ﹤0.01%
2,544,675
AFFY
1837
DELISTED
Affymax Inc
AFFY
$2 ﹤0.01%
500
ACGL icon
1838
Arch Capital
ACGL
$36.1B
-9,234
Closed -$580K
ACHC icon
1839
Acadia Healthcare
ACHC
$3.17B
-27
Closed -$2K
AENTW icon
1840
Alliance Entertainment Holding Corp Warrants
AENTW
-100
Closed
AEON icon
1841
AEON Biopharma
AEON
$11.1M
-233
Closed -$169K
AIG icon
1842
American International
AIG
$41.9B
-12
Closed -$1K
ALNY icon
1843
Alnylam Pharmaceuticals
ALNY
$36.3B
-2
Closed
ALTI icon
1844
AlTi Global
ALTI
$378M
-21,583
Closed -$236K
ARCB icon
1845
PUT
ArcBest
ARCB
$3.44B
-500
Closed -$295K
ARKW icon
1846
ARK Web x.0 ETF
ARKW
$1.64B
-19
Closed -$1K
ASIX icon
1847
AdvanSix
ASIX
$567M
-8
Closed
AVDX
1848
DELISTED
AvidXchange
AVDX
-1,087,866
Closed -$10.8M
BETR icon
1849
Better Home & Finance Holding
BETR
$412M
-180
Closed -$91K
BIPC icon
1850
Brookfield Infrastructure
BIPC
$5.11B
-24
Closed -$1K

Similar funds

Ancora Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Ancora Advisors held 2,322 positions worth $3.53B, up 1.6% from $3.47B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ancora Advisors's Q1 2023 filing shows 188 new, 441 increased, 443 reduced and 332 closed positions. Its largest new stake was Green Brick Partners: 3,556,800 shares worth $589K. The largest sale was IAA, Inc. Common Stock, an estimated $188M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Ancora Advisors's largest Q1 2023 buy was Green Brick Partners: 3,556,800 shares worth $589K.
  • Ancora Advisors added most to RB Global in Q1 2023, an estimated $166M increase.
  • Ancora Advisors's biggest Q1 2023 reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, cutting an estimated $16.6M.
  • Ancora Advisors fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $188M.
  • Ancora Advisors's ten largest holdings make up 29% of its $3.53B portfolio in Q1 2023.
  • Ancora Advisors opened 188 new positions and closed 332 in Q1 2023.
  • Ancora Advisors's portfolio value rose 1.6% quarter-over-quarter to $3.53B.

Based on Ancora Advisors's 13F filing for Q1 2023, filed 16 May 2023.